Xp11.2 Translocation Renal Cell Carcinoma in an Elderly Woman: A Diagnostic Challenge – A Case Report
Case Reports in Oncology · 26.08.2026 · 19 (1) · 1698-1703
DOI: 10.1159/cro/abzag041 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Oncology, online erschienen am 26.08.2026. Verfasst von Noboru Inoue und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Center of Clinical Education, Tokushima Prefectural Central Hospital, Tokushima, Japan. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Xp11.2 translocation renal cell carcinoma (Xp11.2 tRCC) is a rare subtype of renal cell carcinoma (RCC) characterized by transcription factor E3 (TFE3) gene rearrangements. It typically occurs in children and young adults, but cases in older patients have also been reported. An accurate diagnosis of Xp11.2 tRCC is often challenging because of its overlapping histological features with other RCC subtypes. Case Presentation: We report the case of a 68-year-old woman who was diagnosed preoperatively with left RCC, clinical stage cT1aN0M0, and underwent robot-assisted partial nephrectomy. The gross and histological tumor findings were atypical for clear cell RCC (ccRCC), suggesting ccRCC with numerous granular tumor cells. Immunohistochemistry (IHC) showed focal positivity for CA9 and cytokeratin (AE1/AE3), negativity for c-kit, and positivity for PAX8. Initial consultation suggested that microphthalmia-associated transcription factor family tRCC was less likely because of negativity for human melanoma black 45 and Melan-A, and the tumor was diagnosed as ccRCC (WHO/ISUP grade 3, pT1a). However, additional IHC results revealed nuclear positivity for TFE3, and subsequent consultation demonstrated break-apart and fusion signals on TFE3 break-apart fluorescence in situ hybridization (FISH), confirming the diagnosis of Xp11.2 tRCC. The patient remained disease-free for >4 years postoperatively.
Conclusions
This case illustrates the diagnostic difficulty of Xp11.2 tRCC, particularly in atypical renal tumors, and emphasizes the possibility of such cases being overlooked. The limited availability of facilities capable of performing TFE3 IHC and FISH highlights the need for heightened awareness and molecular testing for the accurate diagnosis and management of this rare tumor.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Center of Clinical Education, Tokushima Prefectural Central Hospital, Tokushima, Japan.
- Department of Urology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
- Department of Pathology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
- Department of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Zitieren
APA
Inoue, N., Fukuta, K., Satake, N., Atagi, Y., Ozaki, K., Nakashima, T., Nakanishi, R., Izaki, H., & Furukawa, J. (2026). Xp11.2 Translocation Renal Cell Carcinoma in an Elderly Woman: A Diagnostic Challenge – A Case Report. Case Reports in Oncology, 19(1), 1698-1703. https://doi.org/10.1159/cro/abzag041
Vancouver
Inoue N, Fukuta K, Satake N, Atagi Y, Ozaki K, Nakashima T, et al. Xp11.2 Translocation Renal Cell Carcinoma in an Elderly Woman: A Diagnostic Challenge – A Case Report. Case Reports in Oncology. 2026;19(1):1698-1703. doi:10.1159/cro/abzag041
BibTeX
@article{Inoue2026,
author = {Inoue, Noboru and Fukuta, Kyotaro and Satake, Nobuo and Atagi, Yuichiro and Ozaki, Keisuke and Nakashima, Takeshi and Nakanishi, Ryoichi and Izaki, Hirofumi and Furukawa, Junya},
title = {Xp11.2 Translocation Renal Cell Carcinoma in an Elderly Woman: A Diagnostic Challenge – A Case Report},
journal = {Case Reports in Oncology},
year = {2026},
volume = {19},
number = {1},
pages = {1698--1703},
doi = {10.1159/cro/abzag041}
}
EUVIMED